TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Maslinic acid, Gemcitabine
Phytochemical Name Maslinic acid (PubChem CID: 73659 )
Anticancer drug Name Gemcitabine (PubChem CID: 60750 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 222
Pair Name Maslinic acid, Gemcitabine
Disease Info [ICD-11: 2C94] Bladder cancer Investigative
Biological Phenomena Induction-->Apoptosis
Gene Regulation Down-regulation Expression BAX hsa581
Down-regulation Expression BCL2 hsa596
Down-regulation Expression CCND1 hsa595
Down-regulation Expression MMP2 hsa4313
Down-regulation Expression MMP9 hsa4318
Down-regulation Activity NFKB1 hsa4790
In Vitro Model EH-GB1 Gallbladder carcinoma Homo sapiens (Human) CVCL_IU73
EH-GB2 Gallbladder carcinoma Homo sapiens (Human) CVCL_6899
GBC-SD Gallbladder carcinoma Homo sapiens (Human) CVCL_6903
In Vivo Model EH-GB2 tumor cells were subcutaneously injected into the mice (2×10⁶ cells/mouse).
Result The results suggest that MA potentiates the antitumor effects of GEM in human GBC cell lines by suppressing the activation of NF-κB and its dowstream gene products, which are involved in survival signaling.
03. Reference
No. Title Href
1 Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells. Oncol Rep. 2015 Apr;33(4):1683-90. doi: 10.3892/or.2015.3755. Click
It has been 48351 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP